PlainRecalls
FDA Drug Moderate Class II Terminated

Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC 0591-3695-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054

Reported: October 31, 2018 Initiated: August 6, 2018 #D-0097-2019

Product Description

Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC 0591-3695-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054

Reason for Recall

Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
3,785 bottles
Distribution
Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC 0591-3695-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054. Recalled by Teva Pharmaceuticals USA. Units affected: 3,785 bottles.
Why was this product recalled?
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 31, 2018. Severity: Moderate. Recall number: D-0097-2019.